Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 22Recruiting 8Unknown 2Active not recruiting 2Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 630Prostatic Neoplasms 372Neoplasms 305Carcinoma, Non-Small-Cell Lung 215Lung Neoplasms 204Colorectal Neoplasms 176Multiple Myeloma 143Pancreatic Neoplasms 136Leukemia, Myeloid, Acute 128Neoplasm Metastasis 124Brain Neoplasms 117Melanoma 116Ovarian Neoplasms 101Carcinoma, Hepatocellular 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 100Glioblastoma 99Uterine Cervical Neoplasms 97Head and Neck Neoplasms 94Squamous Cell Carcinoma of Head and Neck 93Colonic Neoplasms 82Stomach Neoplasms 80Recurrence 80Rectal Neoplasms 80Urinary Bladder Neoplasms 77Sarcoma 77Carcinoma, Renal Cell 76Triple Negative Breast Neoplasms 75Lymphoma 71Lymphoma, Non-Hodgkin 67Leukemia, Lymphocytic, Chronic, B-Cell 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Neurofibromatoses × Clear all
NCT03873610 2025-12-26

Resiliency Training in Adolescents With NF1 and NF2

Massachusetts General Hospital

Phase NA Active not recruiting
200 enrolled
CNS

Neurofibromatoses

NCT05581511 2025-10-14

cNF Natural Hx

Johns Hopkins University

Active not recruiting
500 enrolled
CNS

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡